Veracyte Inc.
42.53
1.47 (3.58%)
At close: Jan 15, 2025, 10:40 AM

Veracyte Inc. Revenue Breakdown

Quarter Sep 30, 2024Mar 31, 2024Dec 31, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Sep 30, 2019Jun 30, 2019Mar 31, 2019Sep 30, 2018
Biopharmaceutical And Other Revenue 3.14M 3.00M 18.92M 4.56M 6.13M 6.80M 7.70M 10.04M 8.82M 11.16M 6.51M 2.69M 3.06M 2.70M 2.03M 1.71M 5.06M 90.00K 90.00K 90.00K 0
Biopharmaceutical And Other Revenue Growth +4.39% -84.12% +314.75% -25.63% -9.75% -11.74% -23.28% +13.76% -20.96% +71.38% +142.34% -12.13% +13.46% +33.00% +18.33% -66.13% +5520.00% 0.00% 0.00% n/a n/a
Product Revenue 3.19M 3.54M 15.59M 4.01M 3.89M 3.23M 3.31M 3.11M 2.98M 16.37M 2.96M n/a n/a 31.50M n/a n/a 37.56M n/a n/a n/a n/a
Product Revenue Growth -9.87% -77.31% +288.63% +3.06% +20.46% -2.50% +6.63% +4.33% -81.80% +453.09% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Testing Revenue 109.54M 90.30M 326.54M 81.75M 72.40M 70.27M 64.58M 59.72M n/a n/a 16.07M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Testing Revenue Growth +21.30% -72.35% +299.44% +12.92% +3.03% +8.81% +8.14% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a

Revenue by Geography

Quarter Dec 31, 2022Dec 31, 2021Dec 31, 2020
Non-Us Revenue 33.61M 18.53M 7.87M
Non-Us Revenue Growth +81.38% +135.51% n/a
United States Revenue 262.92M 200.98M 109.61M
United States Revenue Growth +30.82% +83.35% n/a

Operating Expense Breakdown

Quarter Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017Sep 30, 2017Jun 30, 2017Mar 31, 2017Dec 31, 2016Sep 30, 2016Jun 30, 2016Mar 31, 2016Dec 31, 2015Sep 30, 2015Jun 30, 2015Mar 31, 2015
Selling, General, and Administrative Revenue 48.35M 54.86M 49.03M 46.16M 40.68M 50.80M 48.59M 42.34M 43.28M 43.26M 44.15M 41.06M 47.46M 34.71M 62.17M 25.56M 19.11M 21.14M 25.03M 22.76M 19.35M 20.55M 19.02M 16.71M 17.52M 17.41M 19.29M 14.40M 15.08M 16.43M 15.67M 11.56M 15.02M 16.42M 15.26M 12.21M 13.63M 14.31M 13.10M
Selling, General, and Administrative Revenue Growth -11.86% +11.90% +6.20% +13.49% -19.93% +4.55% +14.78% -2.18% +0.03% -2.00% +7.52% -13.49% +36.74% -44.17% +143.22% +33.76% -9.62% -15.53% +9.95% +17.65% -5.82% +8.01% +13.82% -4.64% +0.65% -9.75% +33.96% -4.49% -8.23% +4.84% +35.61% -23.06% -8.50% +7.56% +25.02% -10.40% -4.77% +9.25% n/a
Research and Development Revenue 17.57M 16.22M 15.73M 18.41M 13.32M 12.54M 12.77M 11.29M 10.77M 9.38M 9.17M 10.25M 2.20M 6.25M 5.34M 4.59M 4.04M 1.26M 4.41M 4.44M 3.64M 3.33M 3.44M 3.13M 1.18M 2.21M 1.06M 3.20M 847.00K 1.36M 1.71M 3.59M 1.83M 2.19M 1.49M 3.34M 1.71M 1.27M 1.11M
Research and Development Revenue Growth +8.37% +3.12% -14.59% +38.21% +6.23% -1.79% +13.13% +4.77% +14.89% +2.30% -10.59% +365.79% -64.78% +17.11% +16.35% +13.46% +219.53% -71.30% -0.81% +21.96% +9.40% -3.06% +9.92% +165.28% -46.77% +109.37% -66.99% +278.04% -37.63% -20.68% -52.31% +95.64% -16.02% +46.35% -55.34% +95.04% +35.07% +14.43% n/a
Sales and Marketing Revenue 22.61M 7.13M 6.16M 7.10M 24.34M 25.76M 26.13M 24.13M 25.68M 6.74M 4.97M 22.21M 21.67M 19.66M 3.43M 13.15M 10.96M 2.00M 17.58M 14.18M 13.09M 13.94M 12.48M 10.07M 10.08M 9.62M 11.54M 9.04M 7.88M 7.99M 7.34M 5.83M 7.09M 8.26M 7.07M 6.69M 6.05M 6.94M 5.62M
Sales and Marketing Revenue Growth +216.92% +15.83% -13.26% -70.83% -5.48% -1.43% +8.30% -6.04% +280.98% +35.59% -77.62% +2.50% +10.21% +473.74% -73.94% +20.03% +446.66% -88.60% +23.98% +8.37% -6.13% +11.75% +23.95% -0.15% +4.76% -16.63% +27.62% +14.71% -1.36% +8.97% +25.79% -17.71% -14.23% +16.94% +5.67% +10.57% -12.82% +23.43% n/a

Create Price Alert on VCYT

Your price alert will notify you when the stock price is above 42.53.

Add to Watchlist